Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Pharmacokinetic Comparability Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Subjects

NCT05274100 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05274100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Pharmacokinetic Comparability Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Subjects
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2020
Completion date
July 6, 2021
Enrollment
394 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers